Latest Pharmaceuticals policy Stories
DALLAS, March 2, 2015 /PRNewswire/ -- LifeScienceIndustryResearch.com announces Global Angiographic X-ray System Industry 2015 Market Research Report of 178 pages along
WASHINGTON, March 1, 2015 /PRNewswire-USNewswire/ -- USPlabs has notified the Food and Drug Administration (FDA) of the following and states that media reports saying that a company product
The U.S. Drug Enforcement Agency hosted the National Prescription Drug Take-Back Day from 2000 through 2004.
Medicare Part D Provision Will Curb Prescription Drug Fraud, Waste, and Abuse Washington DC (PRWEB) February 27, 2015 Legislation passed today by the
RIDGEWOOD, N.J., Feb.
DALLAS, February 27, 2015 /PRNewswire/ -- The OTC (Over-The-Counter) market in Central Europe report contains relevant information about growth, value, manufacturing, investment,
DALLAS, February 26, 2015 /PRNewswire/ -- LifeScienceIndustryResearch.com adds Global Pharma US & EU Outlook 2015: First -In- Class Innovations and Cost Optimization
- Strengthens dermatology product pipeline with rights to three products - MISSISSAUGA, ON, Feb. 26, 2015 /PRNewswire/ - Cipher Pharmaceuticals Inc.
BOSTON, February 25, 2015 /PRNewswire/ -- Smooth Drug Development [http://smoothdd.com/en ] announced gaining the internationally renowned ISO 9001:2008 certification [http://en.wikipedia.org/wiki/ISO_9000#Summary_of_ISO_9001:2008_in_informal_language
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.